MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,055K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable and accrued exp...
Proceeds from notes payable issu...
Accounts receivable
Others
Negative Cash Flow Breakdown
Net loss
Payments of notes payable
Inventories
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-3,335
-1,951
-2,076
-3,465
Tax benefit recognized on unrealized gain on debt securities
-
-
-578
591
Depreciation and amortization
15
15
15
9
Inventory reserve
4
-111
4
-4
Amortization of discount of notes payable and convertible notes payable
164
191
142
227
(gain) loss on leased assets
-
0
0
861
Foreign exchange adjustments
22
177
72
-211
Realized loss on investment in convertible bond
-
0
0
-531
Loss on debt extinguishment
-76
-691
-296
-376
Share-based compensation
1
7
9
9
Change in fair value of warrant derivative liabilities
-2
-2
2
-5
Change in fair value of conversion feature derivative, notes payable
-235
0
0
162
Accounts receivable
-756
186
548
-552
Inventories
351
449
-109
-319
Prepaid expenses and other current assets
-294
600
-84
-376
Other long-term liabilities
-
-
-401
-419
Other non-current assets
-30
10
-31
-302
Accounts payable and accrued expenses
1,873
1,578
2,414
2,464
Other liabilities
-1
2,498
-166
-2,516
Operating lease liabilities
-77
-344
-
-
Net cash flows used in operating activities
-344
2,209
409
-2,629
Proceeds from sale of convertible bond
-
0
0
2,172
Purchases of property and equipment
-
0
0
1
Net cash flows provided by investing activities
0
0
0
2,171
Proceeds from notes payable issued
1,112
3,346
1,324
3,238
Payments of notes payable
1,796
3,708
2,326
2,849
Payments of notes payable, related party
9
0
0
240
Payments of convertible notes
9
0
0
210
Net cash flows used in financing activities
-702
-362
-1,002
-61
Effect of exchange rate changes on cash
-9
-13
1
15
Net increase (decrease) in cash and cash equivalents
-1,055
1,834
-592
-504
Cash and cash equivalents, beginning of year
2,127
293
1,389
-
Cash and cash equivalents, end of year
1,072
2,127
293
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase
(decrease) in cash and cash...
-$1,055K
Proceeds from notes
payable issued
$1,112K
Accounts payable and
accrued expenses
$1,873K
Accounts receivable
-$756K
Prepaid expenses and
other current assets
-$294K
Change in fair value of
conversion feature...
-$235K
Amortization of discount of
notes payable and...
$164K
Loss on debt
extinguishment
-$76K
Other non-current
assets
-$30K
Depreciation and
amortization
$15K
Change in fair value of
warrant derivative...
-$2K
Share-based compensation
$1K
Net cash flows used
in financing...
-$702K
Net cash flows used
in operating...
-$344K
Effect of exchange rate
changes on cash
-$9K
Canceled cashflow
$1,112K
Canceled cashflow
$3,446K
Payments of notes payable
$1,796K
Net loss
-$3,335K
Payments of convertible
notes
$9K
Payments of notes
payable, related party
$9K
Inventories
$351K
Operating lease
liabilities
-$77K
Foreign exchange
adjustments
$22K
Inventory reserve
$4K
Other liabilities
-$1K
Buy us a coffee
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)